Integrated BioPharma, Inc. (INBP)

USD 0.3

(-3.71%)

Annual Income Statements

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 50.31 Million 50.67 Million 56.24 Million 63.55 Million 52.76 Million 49.97 Million
Cost of Revenue 46.43 Million 46.61 Million 49.69 Million 54.07 Million 46.04 Million 43.75 Million
Gross Profit 3.88 Million 4.06 Million 6.55 Million 9.48 Million 6.72 Million 6.22 Million
Operating Expenses 3.63 Million 3.94 Million 3.8 Million 3.69 Million 3.46 Million 3.51 Million
Selling, General and Administrative Expenses 3.63 Million 3.94 Million 3.8 Million 3.69 Million 3.46 Million 3.51 Million
Research and Development Expenses - - - - - -
Other Expenses - 40 Thousand -93 Thousand 57 Thousand -274 Thousand -18 Thousand
Cost and Expenses 50.06 Million 50.55 Million 53.5 Million 57.77 Million 49.51 Million 47.27 Million
Operating Income 251 Thousand 120 Thousand 1.96 Million 5.78 Million 2.38 Million 2.7 Million
Interest Expense - 40 Thousand 107 Thousand 256 Thousand 397 Thousand 630 Thousand
Income Tax Expense 156 Thousand 134 Thousand -1.24 Million -766 Thousand -1.02 Million 354 Thousand
Earnings before Tax 268 Thousand 100 Thousand 2.59 Million 7.24 Million 3.08 Million 2.04 Million
Net Income 112 Thousand -34 Thousand 3.83 Million 8.01 Million 4.1 Million 1.68 Million
Earnings Per Share Basic 0.00 -0.00 0.13 0.27 0.14 0.06
Earnings Per Share Diluted 0.00 -0.00 0.12 0.25 0.13 0.06
Weighted Average Shares Outstanding 30.06 Million 29.94 Million 29.84 Million 29.69 Million 29.57 Million 28.93 Million
Weighted Average Shares Outstanding (Diluted) 30.87 Million 29.94 Million 32.32 Million 32.11 Million 31.15 Million 29.58 Million
Gross Margin 0.08 0.08 0.12 0.15 0.13 0.12
EBIT Margin 0.03 0.03 0.05 0.10 0.06 0.07
Profit Margin 0.00 -0.00 0.07 0.13 0.08 0.03
EBITDA 1.47 Million 1.27 Million 3.55 Million 8.32 Million 4.25 Million 3.44 Million
Earnings Before Tax Margin 0.00 0.00 0.03 0.09 0.05 0.05

Income Statement Charts